CDC25B and cancer: Three CDC25 isoforms exist in mammalian cells and their overexpression, particularly CDC25A and B, are commonly reported in a wide variety of human cancers, with CDC25B overexpression in particular, being associated with more advanced disease and poor clinical outcome (reviewed in 12–14).